Evidence map›Paper›PMID 31025493›Full record

ArticleBipolar disorders2020

Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT.

Jared W Young, Mark A Geyer, Adam L Halberstadt, Jordy van Enkhuizen, Arpi Minassian, Asma Khan, William Perry, Lisa T Eyler

Open access · greenAbstract read
In one paragraph

Article in Bipolar disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Developmental Manipulation-Induced Changes in Cognitive Functioning.Current topics in behavioral neurosciences · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2021
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jared W YoungDepartment of Psychiatry, University of California San Diego, California.ORCID 0000-0003-3732-5776
Mark A GeyerDepartment of Psychiatry, University of California San Diego, California.
Adam L HalberstadtDepartment of Psychiatry, University of California San Diego, California.
Jordy van EnkhuizenDepartment of Psychiatry, University of California San Diego, California.
Arpi MinassianDepartment of Psychiatry, University of California San Diego, California.
Asma KhanDepartment of Psychiatry, University of California San Diego, California.
William PerryDepartment of Psychiatry, University of California San Diego, California.
Lisa T EylerDepartment of Psychiatry, University of California San Diego, California.
University of California San Diego · USUtrecht University · NL

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
SAN DIEGO CLINICAL AND TRANSLATIONAL RESEARCH INSTITUTEUL1RR031980 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2010 to 2011
$14.0M
Cross-species studies of smoking effects on cognition and neuroinflammation in HIVR01DA044909 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRODY, ARTHUR, YOUNG, JARED WILLIAM · 2017 to 2021
$4.3M
Inhibitory Deficits in Mania and Hyperdopaminiergic MiceR01MH071916 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GEYER, MARK A, PERRY, WILLIAM · 2004 to 2014
$4.2M
Cannabis use and the endocannabinoid system in bipolar disorderR01DA043535 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PERRY, WILLIAM, YOUNG, JARED WILLIAM · 2018 to 2022
$3.3M
A model organism of brain circuitry and behavioral switching for bipolar disorderR01MH104344 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YOUNG, JARED WILLIAM · 2014 to 2017
$1.7M
The Next Generation of Hallucinogens: A New Class of Synthetic Psychoactive DrugsR01DA041336 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HALBERSTADT, ADAM L. · 2017 to 2020
$1.4M
Neurophysiological biomarkers of behavioral dimensions from cross-species paradigmsUH3MH109168 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YOUNG, JARED WILLIAM · 2018 to 2019
$1.0M
The rodent continuous performance task: Filling the vigilance translational gapR21MH085221 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YOUNG, JARED WILLIAM · 2009 to 2010
$418k
NCATS NIH HHS UL1 TR001442NCRR NIH HHS UL1 RR031980NIDA NIH HHS R01 DA041336NIDA NIH HHS R01 DA043535NIDA NIH HHS R01 DA044909NIMH NIH HHS R01 MH071916NIMH NIH HHS R01 MH104344NIMH NIH HHS R21 MH085221NIMH NIH HHS UH3 MH109168
6 · The paper itself

Abstract

objectivesBipolar disorder (BD) is a debilitating psychiatric illness affecting 2%-5% of the population. Although mania is the cardinal feature of BD, inattention and related cognitive dysfunction are observed across all stages. Since cognitive dysfunction confers poor functional outcome in patients, understanding the relevant neural mechanisms remains key to developing novel-targeted therapeutics.

methodsThe 5-choice continuous performance test (5C-CPT) is a mouse and fMRI-compatible human attentional task, requiring responding to target stimuli while inhibiting responding to nontarget stimuli, as in clinical CPTs. This task was used to delineate systems-level neural deficits in BD contributing to inattentive performance in human subjects with BD as well as mouse models with either parietal cortex (PC) lesions or reduced dopamine transporter (DAT) expression.

resultsMania BD participants exhibited severe 5C-CPT impairment. Euthymic BD patients exhibited modestly impaired 5C-CPT. High impulsivity BD subjects exhibited reduced PC activation during target and nontarget responding compared with healthy participants. In mice, bilateral PC lesions impaired both target and nontarget responding. In the DAT knockdown mouse model of BD mania, knockdown mice exhibited severely impaired 5C-CPT performance versus wildtype littermates.

conclusionsThese data support the role of the PC in inattention in BD-specifically regarding identifying the appropriate response to target vs nontarget stimuli. Moreover, the findings indicate that severely reduced DAT function/hyperdopaminergia recreates the attentional deficits observed in BD mania patients. Determining the contribution of DAT in the PC to attention may provide a future target for treatment development.

Indexed as

Bipolar DisorderAdultAnimalsAttentionCognitionDisease Models, AnimalDopamine Plasma Membrane Transport ProteinsFemaleHumansMagnetic Resonance ImagingMaleMiceMice, KnockoutMiddle AgedSynaptic TransmissionTask Performance and AnalysisDopamine Plasma Membrane Transport Proteinsattentiongenelesionmaniaparietal cortexVigilance

Identifiers

PMID31025493
PMCPMC6815232
OpenAlexW2941030549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.